Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Farmasotik Kimya
Articles 8 YÖKSİS 8 · OpenAlex 0 Total citations 83 h-index 4 · OpenAlex OpenAlex coverage %100 matched 8 / 8 Q1 articles 2 Scopus · WoS Q1 3 Co-authors 17 3 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 8
h-index 4 Percentile in Türkiye: 52 #1,359 of 2,201 at their university by h-index
i10-index
3
Total citations
83
Top 40% in Türkiye
Per article
10.4
FWCI
1.98
1.00 = world average
World top 1%
0
World top 10%
2
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Citing publications Crossref 16 publications citing 8 DOI-bearing articles · 4 Türkiye-affiliated
  • 2019 1
  • 2020 3
  • 2021 6
  • 2022 2
  • 2025 3
  • 2026 1
  1. DOI 10.1039/d5qo01484k 2026
  2. DOI 10.1186/s12974-025-03623-z 2025
  3. DOI 10.3390/ph18121859 2025
  4. DOI 10.1080/13543776.2025.2585821 2025
  5. DOI 10.1007/s43450-022-00235-z 2022
  6. DOI 10.1039/d1ra06149f 2022
  7. Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020 TR Eslam Roshdy et al. · European Journal of Medicinal Chemistry · 2021
  8. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT TR Semih Yagci et al. · Bioorganic & Medicinal Chemistry · 2021
  9. The potential of 4-aryl-6-morpholino-3(2H)-pyridazinone-2-arylpiperazinylacetamide as a new scaffold for SIRT2 inhibition: in silico approach guided by pharmacophore mapping and molecular docking TR Murat Kadir Sukuroglu et al. · Medicinal Chemistry Research · 2021 · cites 2 articles of this academic
  10. DOI 10.1039/d0ra07971e 2021
  11. DOI 10.1039/d0cb00036a 2021
  12. DOI 10.3389/fphar.2020.585821 2021
  13. Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening TR Fikriye Ozgencil et al. · Bioorganic & Medicinal Chemistry · 2020
  14. DOI 10.1101/2020.03.20.000380 2020
  15. DOI 10.1039/c9ra09211k 2020
  16. DOI 10.1039/c9ra03281a 2019
Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Field ranking

Position in the main-field, side-field and keyword cohorts by YÖKSİS article score; each card opens that ranking.

Works 8

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 0 articles
OpenAlex citation percentile
Top 1%0
Top 10%2
Avg · n 8 %73.4
Other counts

Scopus (SJR)

  • YÖKSİS rows 8

WoS (JCR)

  • YÖKSİS rows 8

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

8articles

Journals with publications

6 journals

Narrow down

Scopus (SJR)
Q12 Q25 Q31 Q40
WoS (JCR)
Q13 Q24 Q31 Q40
TR Index
0articles

Article list

  1. 2026 Probing Chiral Recognition on Amylose Tris(3,5‐Dimethylphenylcarbamate) Using Cinnamyl 2‐Aminoanilides: The Subtle Impact of Aliphatic Substituents ELECTROPHORESIS DOI 10.1002/elps.70109 YÖKSİS SJR Q3 JCR Q3 OpenAlex 34.5%
  2. 2026 Structure‐Guided Optimization and Biological Validation of 1,3,4‐Thiadiazole‐Based SIRT2 Inhibitors Reinforcing Channel Entrance Interactions Drug Development Research DOI 10.1002/ddr.70256 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 96.4%
  3. 2024 2‐(Methyl(phenyl)amino)‐N‐(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition Drug Development Research DOI 10.1002/ddr.22224 YÖKSİS SJR Q2 JCR Q1 OpenAlex 72.1%
  4. 2024 Selective inhibition of SIRT2: A disputable therapeutic approach in cancer therapy Bioorganic Chemistry DOI 10.1016/j.bioorg.2023.107038 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 93.3%
  5. 2024 Symmetrical 2,7‐disubstituted 9H‐fluoren‐9‐one as a novel and promising scaffold for selective targeting of SIRT2 ARCHIV DER PHARMAZIE DOI 10.1002/ardp.202400661 YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.3%
  6. 2022 Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity Bioorganic Chemistry DOI 10.1016/j.bioorg.2022.105746 YÖKSİS SJR Q1 JCR Q1 OpenAlex 68.1%
  7. 2021 Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT BIOORGANIC & MEDICINAL CHEMISTRY DOI 10.1016/j.bmc.2020.115961 YÖKSİS SJR Q2 JCR Q2 OpenAlex 67.3%
  8. 2019 Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors JOURNAL OF MOLECULAR GRAPHICS & MODELLING DOI 10.1016/j.jmgm.2019.02.014 YÖKSİS SJR Q2 JCR Q2 OpenAlex 82.0%

Projects 4

  1. 2025 Design, synthesis, and biological evaluation of SIRT3 activators/LSD1 inhibitors as dual hybrids towards an innovative therapeutic approach in cancer treatment Diğer Resmi Kurum ve Kuruluşlar · Tamamlandı 2025-01-07 – 2026-02-25
  2. 2022 Yeni 2,7-Disübstitüe 9H-Fluoren-9-on Türevleri: Tasarımı, Sentezi ve SIRT2 İnhibitör Etkilerinin Araştırılması TÜSEB · Tamamlandı 2022-10-28 – 2024-01-11
  3. 2021 Öncü Bileşik Optimizasyonu ile Yeni Selektif SIRT2 İnhibitörlerin Geliştirilmesi Yükseköğretim Kurumları tarafından destekli bilimsel araştırma projesi · Tamamlandı 2021-08-26 – 2024-01-15
  4. 2018 Yeni Selektif SIRT2 İnhibitörlerinin Tasarımı, Sentezi, Biyolojik Aktivitelerinin Tayini ve Yapı-Etki İlişkilerinin İncelenmesi -Tübitak 1001 · Tamamlandı 2018-11-15 – 2022-09-28

Proceedings 4

  1. 2022 In Silico Hit Optimization toward SIRT2 Inhibition: N-aryloxyaryl-2-(arylthio)acetamides 9th EFMC Young Medicinal Chemists' Symposium (EFMC-YMCS 2022)
  2. 2021 SIRT2 Inhibitory Activities of N-Aryloxyphenyl-2-(arylthio)acetamide Derivatives GPSS-2021, 3rd International Gazi Pharma Symposium Series
  3. 2024 Ariloksiaril Asetamit Yapısında Sirtuin İnhibitörü Olabilecek Bileşiklerin Tasarımı, Sentezi ve Biyolojik Aktivite Çalışmaları VII. Ulusal Farmasötik Kimya Kongresi
  4. 2019 Design and Synthesis of Aryloxy Benzamide Derivatives with Potential Inhibitory Effect against SIRT2 EFMC-YMCS, 6th EFMC Young Medicinal Chemist Symposium

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
17
With an akaturk profile
9
Turkish institutions
3
Co-authored works
%100

Academic co-authors 9

  1. GÖKÇEN EREN Profesör · Gazi Üniversitesi same university 7
  2. FİLİZ BAKAR ATEŞ Profesör · Ankara Üniversitesi 5
  3. MAHMUT GÖZELLE Doktor Öğretim Üyesi · Gazi Üniversitesi same university 5
  4. YEŞİM ÖZKAN Profesör · Gazi Üniversitesi same university 5
  5. AHMET BUĞRA AKSEL Araştırma Görevlisi · Karadeniz Teknik Üniversitesi 3
  6. ERVA ÖZKAN Doktor Öğretim Üyesi · Ankara Medipol Üniversitesi 3
  7. HABİBE BEYZA GÜNİNDİ Araştırma Görevlisi · Gazi Üniversitesi same university 2
  8. FİKRİYE ÖZGENCİL Araştırma Görevlisi · Gazi Üniversitesi same university 1
  9. YASEMİN DÜNDAR Profesör · Gazi Üniversitesi same university 1

National collaboration 3 institutions

Within own university7 joint works · Gazi Üniversitesi

  1. Ankara Üniversitesi 5 works · 1 academics
  2. Ankara Medipol Üniversitesi 3 works · 1 academics
  3. Karadeniz Teknik Üniversitesi 3 works · 1 academics

Other co-authors (incl. international) 8

ALBERTO MASSAROTTI 3ALESSIA RAUCCIANTONELLO MAICLEMENS ZWERGELRENGÜL ATALAYROBERTO CIRILLISEMİH YAĞCISERGIO VALENTE

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.